Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cells

Immunotherapy is expected to be promising as a next generation cancer therapy. Immunoreceptors are often activated constitutively in cancer cells, however, such levels of ligand expression are not effectively recognized by the native immune system due to tumor microenvironmental adaptation. Studies...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncol Rep
Main Authors: Nakajima, Nakako Izumi, Niimi, Atsuko, Isono, Mayu, Oike, Takahiro, Sato, Hiro, Nakano, Takashi, Shibata, Atsushi
פורמט: Artigo
שפה:Inglês
יצא לאור: D.A. Spandidos 2017
נושאים:
Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5562072/
https://ncbi.nlm.nih.gov/pubmed/28677817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5773
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים